Skip navigation

Innovative Models for Elevating Ethics and Integrity Programs

October 22-24, 2019
  • San Francisco, CA
Benchmark Winning Frameworks for Industry's Top Risk Areas

Patient Interactions / Support Services Third Party Oversight
Drug Pricing Speaker Programs Enforcement Trends HCP Interactions
Promotional Compliance Transparency / Aggregate Spend
Data Privacy / Analytics Market Access / Value Based Contracts
Clinical / R&D Oversight

This year’s event is projected to be the most in-depth and impactful yet
— Don’t miss out on dynamic sessions designed to engage and
educate the life sciences compliance community!

CBI’s 10th Annual Life Sciences West Coast Compliance Congress is industry’s “go-to” event for innovative bio/pharmaceutical, medical device and diagnostic compliance and legal professionals. With new content on third party risk and oversight, ethics and compliance, and drug pricing transparency alongside critical updates on pressing topics including patient assistance program compliance, off-label communication, speaker programs and data privacy, this year is projected to be the most in-depth and impactful yet. Backed by ten years of high-quality content, this congress continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre-launch to commercial, within life sciences.

Can’t Miss Content for Local CCOs
and Their Counterparts:

  • Gain Insight on Drug Pricing Transparency and State Level Legislation
  • Walk through the Evaluation of Corporate Compliance Programs
    New Guidance
  • Benefit from an In-Conference Workshop — Strengthen Speaker Program Compliance through Innovative Initiatives and Best Practices
  • Explore Compliance for Innovative Therapies —
    Rare Disease and Cell and Gene Therapy
  • Employ Data Analytics to Drive Strategic Understandings Around Auditing, Monitoring and Risk Identification

10th Annual Life Sciences West Coast Compliance Congress

Innovative Models for Elevating Ethics and Integrity Programs

Benchmark Winning Frameworks for Industry's Top Risk Areas

Patient Interactions / Support Services Third Party Oversight
Drug Pricing Speaker Programs Enforcement Trends HCP Interactions
Promotional Compliance Transparency / Aggregate Spend
Data Privacy / Analytics Market Access / Value Based Contracts
Clinical / R&D Oversight

This year’s event is projected to be the most in-depth and impactful yet
— Don’t miss out on dynamic sessions designed to engage and
educate the life sciences compliance community!

CBI’s 10th Annual Life Sciences West Coast Compliance Congress is industry’s “go-to” event for innovative bio/pharmaceutical, medical device and diagnostic compliance and legal professionals. With new content on third party risk and oversight, ethics and compliance, and drug pricing transparency alongside critical updates on pressing topics including patient assistance program compliance, off-label communication, speaker programs and data privacy, this year is projected to be the most in-depth and impactful yet. Backed by ten years of high-quality content, this congress continues to elevate the bar in compliance by convening the brightest minds and most influential stakeholders to converse on the unique compliance challenges and risks, from pre-launch to commercial, within life sciences.

Can’t Miss Content for Local CCOs
and Their Counterparts:

  • Gain Insight on Drug Pricing Transparency and State Level Legislation
  • Walk through the Evaluation of Corporate Compliance Programs
    New Guidance
  • Benefit from an In-Conference Workshop — Strengthen Speaker Program Compliance through Innovative Initiatives and Best Practices
  • Explore Compliance for Innovative Therapies —
    Rare Disease and Cell and Gene Therapy
  • Employ Data Analytics to Drive Strategic Understandings Around Auditing, Monitoring and Risk Identification